Integrating Formulation Development and Manufacturing
News Jul 16, 2009
Symyx Technologies Inc. has announced that the latest edition of its technical e-newsletter - Symyx News is now available for free download from www.symyxnews.com.
The June/July issue of Symyx News showcases how Symyx's Contract Development and Manufacturing Organisation (CDMO) has helped pharmaceutical and biotech companies move promising drug candidates to clinical trials faster with integrated formulation development, and preclinical and CGMP fill/finish manufacturing.
Symyx Isentris software is used worldwide by life science organizations to eliminate data silos and make in-house and public scientific information easily accessible to researchers.
The latest issue of Symyx News discusses how the new Discovery Team Space add-in to Isentris now enables R&D teams to share information extracted and analyzed by individual researchers in a collaborative environment. Discovery Team Space effectively pushes information to research teams by providing a gateway for team members to disseminate new search strategies, reports, and insights to colleagues.
The issue also reports on how Symyx Technologies, Inc. has recently been awarded a grant by the United States Department of Energy (DOE) to conduct research and development of advanced heat transfer fluids for solar thermal power generation.
Symyx News - the technical e-newsletter from Symyx Technologies, offers a source of information relating to the latest technical and applications advances, news and new product introductions for scientists looking to keep informed of innovations that assist their research and development programs.
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE